Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2005
09/22/2005US20050207991 Aerosols for administering drugs by breathing and filling canisters with compounds like fluticasone propionate
09/22/2005US20050207990 Stabilised supersaturated solids of lipophilic drugs
09/22/2005US20050207989 High storage stability inhalable compositions
09/22/2005US20050207988 Polysaccharides for pulmonary delivery of active agents
09/22/2005US20050207987 Mixture of tobramycin in carrier; aerosols; respiratory system disorders; drug delivery
09/22/2005US20050207986 Stabilized preparations for use in nebulizers
09/22/2005US20050207985 dispensers containing a mixture of albuterol and ipratropium bromide, used for inducing bronchodialation or providing relief of bronchospasm in in an individual suffering from copd
09/22/2005US20050207984 Physical and chemical stability; homogeneity; particle size range; asthma, chronic obstructive pulmonary disease; 1,1,1,2-tetrafluoroethane and/or 1,1,1,2,3,3,3-heptafluoropropane used as propellants
09/22/2005US20050207983 treatment of respiratory system disorders comprising administering non-surfactant aerosols comprising sodium chloride as a diluent and drugs selected from antibiotics, antihistamines and/or antiviral agents
09/22/2005US20050207980 Stable microbubbles suspensions injectable into living organisms
09/22/2005US20050206023 formation of particles of a target substance, such as a pharmaceutical, using a supercritical or near-critical fluid as an anti-solvent
09/22/2005US20050205107 Dental floss head device with a flavor delivery means
09/22/2005US20050205087 Powder delivery device
09/22/2005US20050205083 Medicament storage and delivery devices
09/22/2005DE20321052U1 Transdermal therapeutic system for delivery of fentanyl, to treat severe and/or chronic pain, including drug-containing adhesive matrix of specific basic acrylate copolymer requiring no penetration accelerators
09/22/2005DE202005010658U1 Animal feed product, useful for administering medicaments (e.g. capsules or tablets) to domestic animals e.g. cats and dogs, comprises body made from dough, which is provided with a cavity and an opening
09/22/2005DE102004011512A1 Pharmazeutische Zubereitung enthaltend Pimobendan Pharmaceutical composition comprising pimobendan
09/22/2005DE102004011349A1 Wässrige Polymerdispersion auf Basis von Alkyl(meth)-acrylaten Acrylates aqueous polymer dispersion based on alkyl (meth)
09/22/2005DE102004009904A1 Kit aus einem gegebenenfalls wirkstoffhaltigen Pflaster und einem Hautirritationen verhindernden Mittel Kit preventing from an optionally medicated plaster and a skin irritation means
09/22/2005DE102004009903A1 Pflaster mit reduzierter Hautirritation Paving with reduced skin irritation
09/22/2005DE10152351B4 Feste Arzneimittelformulierung für ein Piperazinharnstoffderivat Solid pharmaceutical formulation for a Piperazinharnstoffderivat
09/22/2005CA2787978A1 Interferon-beta for anti-virus therapy for respiratory diseases
09/22/2005CA2563739A1 Bioavailable solid dosage forms of metaxalone
09/22/2005CA2560468A1 Temperature sensitive polymers
09/22/2005CA2560176A1 Occlusive biomedical devices, punctum plugs, and methods of use thereof
09/22/2005CA2560079A1 Process for producing medicine
09/22/2005CA2560076A1 Method of preparing a protein aggregate and a pharmaceutical composition
09/22/2005CA2559826A1 Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method
09/22/2005CA2559800A1 Drug delivery system based on immune response system
09/22/2005CA2559351A1 Novel compositions for topical delivery
09/22/2005CA2559062A1 Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
09/22/2005CA2558582A1 Stabilised supersaturated solids of lipophilic drugs
09/22/2005CA2558393A1 Compositions comprising drospirenone molecularly dispersed
09/22/2005CA2558219A1 Poorly water-soluble drug-containing solid formulation
09/22/2005CA2555343A1 Improved efficacy and safety of targeted particulate agents with decoy systems
09/22/2005CA2555250A1 Anti-infectious hydrogel compositions
09/22/2005CA2554547A1 Particulate plant sterol compositions
09/22/2005CA2499220A1 Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury
09/22/2005CA2497942A1 Dental floss head device with a flavor delivery means
09/21/2005EP1577418A1 Polygonal barrel spattering device, polygonal barrel spattering method, coated particle formed by the device and method, microcapsule, and method of manufacturing the microcapsule
09/21/2005EP1577361A1 Spraying composition
09/21/2005EP1577298A1 Process for determining the purity of amlodipine
09/21/2005EP1576986A2 Sustained-release tramadol formulations with 24-hour clinical efficacy
09/21/2005EP1576978A2 Device for administering insulin in controlled dosages by controlling total inhaled volume
09/21/2005EP1576961A1 Pharmaceutical compound containing silymarin and carbopol, production method thereof and use of same as a regenerator of tissue and pancreatic cells with endogenous secretion damaged by diabetes mellitus
09/21/2005EP1576959A1 A coixenolide capsules for treating prostate disease
09/21/2005EP1576953A1 Propofol-containing fat emulsions
09/21/2005EP1576952A1 Hydrogel microspheres with improved release profile
09/21/2005EP1576951A1 Formulations for the rectal administration of thrombolytically-active agents
09/21/2005EP1576105A2 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations
09/21/2005EP1575987A2 Conjugates of membrane translocating agents and pharmaceutically active agents
09/21/2005EP1575976A2 Methods and compositions for therapeutic use of rna interference
09/21/2005EP1575703A1 Method for modifying microparticles and device for modifying microparticles
09/21/2005EP1575696A1 Methods and apparatus for making particles using spray dryer and in-line jet mill
09/21/2005EP1575670A2 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia
09/21/2005EP1575656A1 Insulin delivery system with sensor
09/21/2005EP1575639A2 Drug delivery system for sustained delivery of glipizide
09/21/2005EP1575621A2 Contrast media formulations having improved biological tolerance
09/21/2005EP1575620A2 Bio-degradable microspheres for diagnosing gastroesophagal reflux
09/21/2005EP1575618A2 Dispersible pharmaceutical compositions
09/21/2005EP1575617A1 Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis
09/21/2005EP1575616A2 Novel injectable depot formulations
09/21/2005EP1575600A1 Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations
09/21/2005EP1575597A1 Use of rimexolone in the treatment of dry eye
09/21/2005EP1575588A1 Tiotropium containing hfc solution formulations
09/21/2005EP1575585A1 Pharmaceutical liquid composition containing pyridone derivative
09/21/2005EP1575577A2 Composition for the prevention and treatment of inflammation of the ear
09/21/2005EP1575570A2 Transdermal vaccine delivery device having coated microprotrusions
09/21/2005EP1575569A2 Oral drug delivery system comprising high viscosity liquid carrier materials
09/21/2005EP1575568A1 Use of thickening agents for producing soft capsules and film production method
09/21/2005EP1575566A1 Multilayer dosage forms containing nsaids and triptans
09/21/2005EP1575565A1 Modified-release tablet of bupropion hydrochloride
09/21/2005EP1575564A1 Solid dispersions comprising a hygroscopic and/or deliquescent drug
09/21/2005EP1575563A1 Non-hygroscopic formulation comprising a hydroscopic drug
09/21/2005EP1575562A2 Buoyant polymer particles delivering therapeutic agents
09/21/2005EP1575561A1 Microcapsules having multiple shells and method for the preparation thereof
09/21/2005EP1575560A2 Methods for making pharmaceutical formulations comprising deagglomerated microparticles
09/21/2005EP1575559A1 Dosing aerosols containing lecithin as a surface-active substance
09/21/2005EP1575558A2 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium
09/21/2005EP1575557A1 Process for the chemical stabilization of a solubilized retinoid in a solvent using a base
09/21/2005EP1575555A2 Formulations of finasteride
09/21/2005EP1575554A1 Thin film delivery systems for volatile decongestants
09/21/2005EP1575553A2 In vivo production of cyclic peptides for inhibiting protein-protein interaction
09/21/2005EP1575552A2 Metal-containing materials, compositions and methods
09/21/2005EP1575551A1 Nutritional supplement composition and method
09/21/2005EP1575549A2 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid
09/21/2005EP1575548A2 Compositions and methods for promoting neuronal outgrowth
09/21/2005EP1575543A1 Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
09/21/2005EP1575487A2 Microcrystalline cewllulose compositions
09/21/2005EP1575485A2 Methods for lightening skin and hair
09/21/2005EP1575478A2 A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
09/21/2005EP1575414A2 Methods and devices for detection and therapy of atheromatous plaque
09/21/2005EP1542728A4 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same
09/21/2005EP1450788B1 Use of coumarin or its hydroxy derivative for the treatment of medium or severe vascular and/or lymphatic edema
09/21/2005EP1435965A4 Pharmaceutical compositions and methods for treating cancer
09/21/2005EP1296689B1 Method of administering bisphosphonates
09/21/2005EP1257256B1 Drug carrier pellet production process
09/21/2005EP1200115B1 Multi-dose erythropoietin formulations
09/21/2005EP1189522B1 Use of nanoscale sterols and sterol esters
09/21/2005EP1140091B1 Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia
1 ... 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 1764 1765 1766 1767 1768 1769 1770 ... 2991